Teva Pharmaceuticals

@TevaUSA ↗

Deleted No

Hibernated No

Last Checked April 3, 2023

Created

Tue Nov 08 18:31:00 +0000 2022

Likes

Retweets

Source

Twitter Web App

View Raw Data

JSON Data

View on Twitter

Likely Available

Teva Pharmaceuticals @TevaUSA

Legislation to improve therapeutic equivalence rating determination to drive access to complex generics was one of the many critical fixes left out of the UFA package, Teva’s Brian McCormick notes at #GRxBiosims https://t.co/I42TZTBhWX — PolitiTweet.org

Posted Nov. 8, 2022

Preceded By

Teva Pharmaceuticals @TevaUSA

RT @cecelou18: @US_FDA One of industry’s concerns with the IRA is ensuring “the continued incentives and growth of the generic and the bios… — PolitiTweet.org

Posted Nov. 8, 2022 Retweet

Followed By

Teva Pharmaceuticals @TevaUSA

There are many hurdles in biosimilar development, yet it’s critically important for the industry to forge ahead this critical category, says Teva’s Cory Wohlbach at #GRxBiosims. Biosimilars can help bring affordable medicines to patients and savings to the US healthcare system. https://t.co/THM4KT0uSP — PolitiTweet.org

Posted Nov. 8, 2022